Artiva Biotherapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Artiva Biotherapeutics Inc
Access all reports
Artiva Biotherapeutics Inc. is a biotechnology company focused on developing off-the-shelf, allogeneic natural killer (NK) cell therapies for cancer treatment. The company's therapies utilize NK cell technology combined with advanced genetic engineering and proprietary manufacturing processes to enhance the effectiveness of NK cells in targeting cancer cells. Artiva’s therapeutic platforms are designed to address various cancer types, with an emphasis on scalability and accessibility for patients. Its development pipeline covers multiple forms of immunotherapies aimed at both solid tumors and hematologic malignancies. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
ARTV
Country
🇺🇸 United States